{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:45:23Z","timestamp":1778125523926,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Compared to febrile neutropenia (FN), non-neutropenic fever (NNF) episodes in children with cancer have not been associated with severe outcomes. Risk factors for severe outcomes in FN and NNF episodes in children with cancer from low-middle-income countries (LMIC) are incompletely described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective, observational cohort study was conducted at a tertiary public referral hospital in western Kenya. Inclusion criteria were age \u226414 years, cancer diagnosis, hospitalized, fever &amp;gt;38.5\u00b0C or persistently &amp;gt;38\u00b0C. Neutropenia was an absolute count (ANC) &amp;lt;500 K\/\u00b5L. Severe outcomes were BSI or death. Statistical analysis detected significance between groups and a univariate analysis was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 99 fevers, 54.5% were NNF episodes. Over 66% of NNF episodes were in patients with solid tumors. More severe outcomes were observed in NNF episodes compared to FN [BSI: 7.4% (4\/54) vs. 4.4% (2\/45); death: 7.4% (4\/54) vs. 4.4% (2\/45)], yet no deaths occurred in episodes with BSI. Acute leukemia not in remission (OR= 8.67, 95% CI [CI: 2.3-32.62]; <jats:italic>p<\/jats:italic>= 0.002) and concern for disease relapse (OR= 14.17, 95% CI [2.08-96.3]; <jats:italic>p<\/jats:italic>= 0.012) were significantly associated severe outcomes. Time to antibiotic administration (9 hours) did not differ by ANC. Under half (45.5%) of fever episodes had a blood culture ordered, with 93.9% obtained after administration of antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Non-neutropenic fever episodes had more severe outcomes. Prompt fever management is recommended in all children with cancer treated in an LMIC setting. Pediatric oncology treatment centers in LMICs should rigorously evaluate their fever management clinical practice. Clinical risk factors were identified, but a risk-stratified approach in an LMIC setting is not recommended. Urgent attention is needed to identify areas of clinical improvement.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1575714","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:07:37Z","timestamp":1747030057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe outcomes and risk factors of non-neutropenic fever episodes in hospitalized children with cancer in Kenya"],"prefix":"10.3389","volume":"15","author":[{"given":"Samuel","family":"Kipchumba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Busby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Njenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Dettinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenah","family":"Nyamusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Langat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Olbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry A.","family":"Vik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Nathan","family":"Nessle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Festus","family":"Njuguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2022.2079785","article-title":"Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to clinical implementation","volume":"40","author":"Nessle","year":"2023","journal-title":"Pediatr Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27679","article-title":"Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia","volume":"66","author":"Paolino","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12885-015-1413-8","article-title":"Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009","volume":"15","author":"Mueller","year":"2015","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v123.19","article-title":"Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia","volume":"123","author":"Esbenshade","year":"2017","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/08880018.2015.1102998","article-title":"Fever and neutropenia hospital discharges in children with cancer: A 2012 update","volume":"33","author":"Mueller","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01814","article-title":"Prospective external validation of the esbenshade vanderbilt models accurately predicts bloodstream infection risk in febrile non-neutropenic children with cancer","volume":"42","author":"Zhao","year":"2024","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05056-w","article-title":"Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review","volume":"28","author":"Koenig","year":"2020","journal-title":"Support Care Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.15-6-526","article-title":"Improvements in the management of neutropenic sepsis: lessons learned from a district general hospital","volume":"15","author":"Wells","year":"2015","journal-title":"Clin Med (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B","article-title":"Fever and infection in leukemic patients: a study of 494 consecutive patients","volume":"41","author":"Bodey","year":"1978","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD009031","DOI":"10.1002\/14651858.CD009031.pub2","article-title":"Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event","volume":"3","author":"Rivas-Ruiz","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25275","article-title":"Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer","volume":"62","author":"Esbenshade","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100220","DOI":"10.1016\/j.eclinm.2019.11.013","article-title":"Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules","volume":"18","author":"Haeusler","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29224","article-title":"Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR - Supportive Care for Children with Cancer in Africa","volume":"68","author":"Israels","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13104-019-4569-5","article-title":"Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital","volume":"12","author":"Mohammed","year":"2019","journal-title":"BMC Res Notes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1007769","article-title":"High morbidity and mortality associated with primary bloodstream infections among pediatric patients with cancer at a Guatemalan tertiary referral hospital","volume":"10","author":"Mukkada","year":"2022","journal-title":"Front Public Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30761-7","article-title":"Childhood cancer burden: a review of global estimates","volume":"20","author":"Bhakta","year":"2019","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30273-6","article-title":"Global childhood cancer survival estimates and priority-setting: a simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04701-8","article-title":"Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia","volume":"27","author":"Daniels","year":"2019","journal-title":"Support Care Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04961-4","article-title":"Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review","volume":"28","author":"Koenig","year":"2020","journal-title":"Support Care Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20989","article-title":"Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO)\u2013part II","volume":"48","author":"Howard","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v123.15","article-title":"Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource-limited pediatric oncology hospital","volume":"123","author":"Agulnik","year":"2017","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006156","article-title":"Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western Kenya","volume":"12","author":"Akullian","year":"2018","journal-title":"PloS Negl Trop Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2006.12.008","article-title":"Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade","volume":"11","author":"Kanafani","year":"2007","journal-title":"Int J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13104-019-4520-9","article-title":"Bacteremia in febrile cancer patients in Uganda","volume":"12","author":"Lubwama","year":"2019","journal-title":"BMC Res Notes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s13104-015-1701-z","article-title":"Bloodstream infections in patients with Malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting","volume":"8","author":"Obeng-Nkrumah","year":"2015","journal-title":"BMC Res Notes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4314\/wajm.v29i5.68249","article-title":"Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana","volume":"29","author":"Vanderpuye","year":"2010","journal-title":"West Afr J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","article-title":"Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer","volume":"24","author":"Alexander","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078124","article-title":"Barriers to and facilitators of effective management of fever episodes in hospitalised Kenyan children with cancer: protocol for convergent mixed methods study","volume":"13","author":"Nessle","year":"2023","journal-title":"BMJ Open"},{"key":"B32","unstructured":"NCCN clincal practice guidelines in oncology: prevention and treatment of cancer related infections\n          \n          \n            \n              Baden\n              LR\n            \n            \n              Swaminathan\n              S\n            \n            \n              Angarone\n              M\n            \n            \n              Blouin\n              G\n            \n          \n          \n          2016"},{"key":"B33","article-title":"National healthcare safety network: bloodstream infection event (Central line- associated bloodstream infection and non-central line associated bldostream infection)","author":"Network","year":"2021","journal-title":"Patient Saf Component Manual"},{"key":"B34","article-title":"2019 Kenya Population and Housing Census, Volume I: Population by County and Sub-County","year":"2019"},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12992-018-0366-5","article-title":"Leveraging the power of partnerships: spreading the vision for a population health care delivery model in western Kenya","volume":"14","author":"Mercer","year":"2018","journal-title":"Global Health"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.v69.10","article-title":"An evaluation of the disparities affecting the underdiagnosis of pediatric cancer in Western Kenya","volume":"69","author":"Severance","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J BioMed Inform"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00313","article-title":"Bacterial isolates and characteristics of children with febrile neutropenia on treatment for cancer at a tertiary hospital in Western Kenya","volume":"10","author":"Kipchumba","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10.1002\/pbc.26790","DOI":"10.1002\/pbc.26790","article-title":"Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting","volume":"65","author":"Mukkada","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"ofab307","DOI":"10.1093\/ofid\/ofab307","article-title":"Factors and outcomes related to the use of guideline-recommended antibiotics in patients with neutropenic fever at the Uganda cancer institute","volume":"8","author":"Gulleen","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/OP.23.00583","article-title":"Impact of time-to-antibiotic delivery in pediatric patients with cancer presenting with febrile neutropenia","volume":"20","author":"De Castro","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3776-7","article-title":"Can complications in febrile neutropenia be predicted? Report from a developing country","volume":"25","author":"Oberoi","year":"2017","journal-title":"Support Care Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26333","article-title":"Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India","volume":"64","author":"Das","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2022.905909","article-title":"Do the Expert Recommendations for Implementing Change (ERIC) strategies adequately address sustainment","volume":"2","author":"Nathan","year":"2022","journal-title":"Front Health Serv"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1575714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T06:07:38Z","timestamp":1747030058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1575714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":44,"alternative-id":["10.3389\/fonc.2025.1575714"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1575714","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"article-number":"1575714"}}